Mavorixafor for Patients with Chronic Neutropenic Disorders Treated with G-CSF: Preliminary Response Data and G-CSF Dose Reduction in an Ongoing Phase 2, OpenLabel, Multicenter Study Support Reduction in G-CSF Dosing-MedSci.cn

Mavorixafor for Patients with Chronic Neutropenic Disorders Treated with G-CSF: Preliminary Response Data and G-CSF Dose Reduction in an Ongoing Phase 2, OpenLabel, Multicenter Study Support Reduction in G-CSF Dosing

Warren, JT; Dickerson, KE; Sharathkumar, AA; Walter, JE; Wilson, DB; Adell, KP; Chen, K; Dubuc, S; MacLeod, R; Peters, K; Stewart, M; Taveras, AG; Walkovich, K

BLOOD, 2023; 142 ():

科室
- - 订阅+
  - 更多科室
工具
服务

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Mavorixafor for Patients with Chronic Neutropenic Disorders Treated with G-CSF: Preliminary Response Data and G-CSF Dose Reduction in an Ongoing Phase 2, OpenLabel, Multicenter Study Support Reduction in G-CSF Dosing

科室

工具

服务